Importantly, up-regulation of FZD7 in ESCC clinical samples was significantly correlated with the shorter survival rate, especially that of the early stage of ESCC, and was found to be an independent prognostic marker by multivariate Cox-regression analysis. Here, FZD7 is linked to esophageal squamous cell carcinoma.